Cargando…
P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430917/ http://dx.doi.org/10.1097/01.HS9.0000971668.24670.ab |
| _version_ | 1785091074605187072 |
|---|---|
| author | Shaw, Briony Chung, Eliza Wellard, Cameron Yoo, Edward Bennett, Rory Birks, Callum Johnston, Anna Cheah, Chan Hamad, Nada Simpson, Jock Barraclough, Allison Ku, Matthew Viiala, Nicholas Ratnasingam, Sumita Armytage, Tasman Cochrane, Tara Chong, Geoff Lee, Denise Manos, Kate Keane, Colm Wallwork, Stephanie Opat, Stephen Hawkes, Eliza A |
| author_facet | Shaw, Briony Chung, Eliza Wellard, Cameron Yoo, Edward Bennett, Rory Birks, Callum Johnston, Anna Cheah, Chan Hamad, Nada Simpson, Jock Barraclough, Allison Ku, Matthew Viiala, Nicholas Ratnasingam, Sumita Armytage, Tasman Cochrane, Tara Chong, Geoff Lee, Denise Manos, Kate Keane, Colm Wallwork, Stephanie Opat, Stephen Hawkes, Eliza A |
| author_sort | Shaw, Briony |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430917 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309172023-08-17 P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY Shaw, Briony Chung, Eliza Wellard, Cameron Yoo, Edward Bennett, Rory Birks, Callum Johnston, Anna Cheah, Chan Hamad, Nada Simpson, Jock Barraclough, Allison Ku, Matthew Viiala, Nicholas Ratnasingam, Sumita Armytage, Tasman Cochrane, Tara Chong, Geoff Lee, Denise Manos, Kate Keane, Colm Wallwork, Stephanie Opat, Stephen Hawkes, Eliza A Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430917/ http://dx.doi.org/10.1097/01.HS9.0000971668.24670.ab Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Shaw, Briony Chung, Eliza Wellard, Cameron Yoo, Edward Bennett, Rory Birks, Callum Johnston, Anna Cheah, Chan Hamad, Nada Simpson, Jock Barraclough, Allison Ku, Matthew Viiala, Nicholas Ratnasingam, Sumita Armytage, Tasman Cochrane, Tara Chong, Geoff Lee, Denise Manos, Kate Keane, Colm Wallwork, Stephanie Opat, Stephen Hawkes, Eliza A P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY |
| title | P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY |
| title_full | P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY |
| title_fullStr | P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY |
| title_full_unstemmed | P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY |
| title_short | P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY |
| title_sort | p1193: polatuzumab, bendamustine & rituximab (pola-br) efficacy in relapsed/refractory diffuse large b cell lymphoma (rrdlbcl) trial-ineligible patients: an australian lymphoma registry (lardr) study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430917/ http://dx.doi.org/10.1097/01.HS9.0000971668.24670.ab |
| work_keys_str_mv | AT shawbriony p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT chungeliza p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT wellardcameron p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT yooedward p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT bennettrory p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT birkscallum p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT johnstonanna p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT cheahchan p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT hamadnada p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT simpsonjock p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT barracloughallison p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT kumatthew p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT viialanicholas p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT ratnasingamsumita p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT armytagetasman p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT cochranetara p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT chonggeoff p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT leedenise p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT manoskate p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT keanecolm p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT wallworkstephanie p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT opatstephen p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy AT hawkeselizaa p1193polatuzumabbendamustinerituximabpolabrefficacyinrelapsedrefractorydiffuselargebcelllymphomarrdlbcltrialineligiblepatientsanaustralianlymphomaregistrylardrstudy |